Healthcare provider profile · identity verified

William B Kerns, M.D.

Internal Medicine · SMITHSBURG, MD · NPI 1326003666

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	792	195
Amlodipine Besylate	Amlodipine Besylate	405	107
Lisinopril	Lisinopril	318	83
Losartan Potassium	Losartan Potassium	238	56
Metformin Hcl	Metformin Hcl	230	57
Pravastatin Sodium	Pravastatin Sodium	225	63
Metoprolol Succinate	Metoprolol Succinate	201	51
Escitalopram Oxalate	Escitalopram Oxalate	176	39
Pantoprazole Sodium	Pantoprazole Sodium	161	48
Levothyroxine Sodium	Levothyroxine Sodium	158	43
Omeprazole	Omeprazole	158	42
Hydrochlorothiazide	Hydrochlorothiazide	144	34
Rosuvastatin Calcium	Rosuvastatin Calcium	138	36
Tramadol Hcl	Tramadol Hcl	130	29
Potassium Chloride	Potassium Chloride	124	33
Metoprolol Tartrate	Metoprolol Tartrate	122	35
Glipizide Er	Glipizide	121	26
Montelukast Sodium	Montelukast Sodium	121	29
Jardiance	Empagliflozin	116	18
Furosemide	Furosemide	112	35
Gabapentin	Gabapentin	105	31
Meloxicam	Meloxicam	101	26
Tamsulosin Hcl	Tamsulosin Hcl	97	33
Sertraline Hcl	Sertraline Hcl	95	24
Allopurinol	Allopurinol	90	26
Eliquis	Apixaban	90	24
Famotidine	Famotidine	77	22
Simvastatin	Simvastatin	75	22
Ezetimibe	Ezetimibe	70	20
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	55	14
Albuterol Sulfate Hfa	Albuterol Sulfate	54	22
Clopidogrel	Clopidogrel Bisulfate	54	14
Paroxetine Hcl	Paroxetine Hcl	53	12
Zolpidem Tartrate	Zolpidem Tartrate	53	11
Bupropion Xl	Bupropion Hcl	52	suppressed
Celecoxib	Celecoxib	51	21
Fluticasone Propionate	Fluticasone Propionate	51	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	51	14
Ozempic	Semaglutide	50	suppressed
Prednisone	Prednisone	48	36
Irbesartan	Irbesartan	45	12
Mounjaro	Tirzepatide	45	suppressed
Tizanidine Hcl	Tizanidine Hcl	45	suppressed
Cefuroxime	Cefuroxime Axetil	44	44
Esomeprazole Magnesium	Esomeprazole Magnesium	42	14
Warfarin Sodium	Warfarin Sodium	41	suppressed
Synthroid	Levothyroxine Sodium	40	11
Pioglitazone Hcl	Pioglitazone Hcl	39	12
Naproxen	Naproxen	38	12
Valsartan	Valsartan	38	suppressed
Hydralazine Hcl	Hydralazine Hcl	34	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	34	suppressed
Januvia	Sitagliptin Phosphate	33	suppressed
Mometasone Furoate	Mometasone Furoate	33	suppressed
Atenolol	Atenolol	32	suppressed
Citalopram Hbr	Citalopram Hydrobromide	32	suppressed
Cefdinir	Cefdinir	31	26
Doxazosin Mesylate	Doxazosin Mesylate	31	suppressed
Spironolactone	Spironolactone	31	suppressed
Telmisartan	Telmisartan	31	suppressed
Trulicity	Dulaglutide	31	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	30	suppressed
Lorazepam	Lorazepam	30	suppressed
Alprazolam	Alprazolam	29	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	28	suppressed
Carvedilol	Carvedilol	27	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	26	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Clonidine Hcl	Clonidine Hcl	26	suppressed
Lansoprazole	Lansoprazole	26	suppressed
Propranolol Hcl Er	Propranolol Hcl	26	suppressed
Azithromycin	Azithromycin	23	17
Digoxin	Digoxin	23	suppressed
Duloxetine Hcl	Duloxetine Hcl	23	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	15
Cephalexin	Cephalexin	20	18
Ramipril	Ramipril	20	suppressed
Trazodone Hcl	Trazodone Hcl	20	suppressed
Alendronate Sodium	Alendronate Sodium	19	suppressed
Atropine Sulfate	Atropine Sulfate	19	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Glipizide	Glipizide	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	17	suppressed
Fosinopril Sodium	Fosinopril Sodium	17	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	17	suppressed
Amoxicillin	Amoxicillin	16	16
Hydrocortisone	Hydrocortisone	16	13
Meclizine Hcl	Meclizine Hcl	16	suppressed
Tradjenta	Linagliptin	16	suppressed
Clonazepam	Clonazepam	15	suppressed
Finasteride	Finasteride	15	suppressed
Nebivolol Hcl	Nebivolol Hcl	15	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	13	suppressed
Methylprednisolone	Methylprednisolone	13	13
Nitroglycerin	Nitroglycerin	13	suppressed
Primidone	Primidone	13	suppressed
Promethazine Hcl	Promethazine Hcl	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Bumetanide	Bumetanide	12	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	12	suppressed
Estradiol (Twice Weekly)	Estradiol	12	suppressed
Jantoven	Warfarin Sodium	12	suppressed
Metformin Hcl Er	Metformin Hcl	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Pregabalin	Pregabalin	11	suppressed
Temazepam	Temazepam	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error